logo Edap TMS
Français English US
  • About EDAP TMS
    • A tradition of innovation
    • Business Overview
    • EDAP TMS worldwide
    • Environmental
  • Investors Information
    • News & Events
    • Financial Information
    • Corporate governance
    • Contact US
  • Products & Services
    • Prostate Cancer
      • Focal One
      • EXACTVU™
    • Urinary stones
      • Sonolith i-move
    • Services
      • HIFU Services
      • ESWL Services
      • Customer Care
      • Training
    • HIFU Regulatory Status
  • Clinical Information
    • Prostate cancer
    • Urinary stones
    • Hemiablation study
  • Press
  • Careers
    • Current job offers
    • On-line application
Home  / Clinical Information 
Facebook picto   picto linkdink   picto tiwter

Clinical Information

EDAP-TMS

Prostate Cancer Management

Prostate cancer is a major public health concern, since 36% of cancers diagnosed in men are prostate cancers, far behind is lung cancer (14%) and rectum cancer (10.4%).

 

EDAP-TMS

Stone Management

Urinary tract stones are frequent and affect 2-3% of the world's population with twice as many men affected than women.

 

  • Clinical Information
    • Prostate cancer
    • Urinary stones
    • Hemiablation study
  • Company
    • A tradition of Innovation
    • EDAP TMS Overview
    • Jobs & Career
    • Contact us
  • Products
    • Focal One®
    • ExactVU®
    • Sonolith® i-move
    • Laserlith® i-dust
  • Services
    • HIFU Services
    • ESWL Services
    • Customer Care Center
    • Training
  • EDAP TMS Websites
    • EDAP TMS Japan
    • HIFU patient web site
  • ©EDAP TMS 2014-2023
  • Terms of Use
  • Transparence
  • Contact
/en/clinical-information